Icotinib is a small molecule targeting epidermal growth factor receptor tyrosine kinase. which shows non-inferior efficacy and better safety comparing to gefitinib in previous phase III trial. The present study was designed to further evaluate the efficacy and safety of icotinib in patients with advanced non-small-cell lung cancer (NSCLC) previously treated with platinum-based chemoth... https://mabelandfoxs.shop/product-category/drawing-board/